Elevance Health Files 8-K on Financial Condition, Operations
Ticker: ELV · Form: 8-K · Filed: Jan 24, 2024 · CIK: 1156039
Complexity: simple
Sentiment: neutral
Topics: financial-condition, results-of-operations, 8-K
TL;DR
**Elevance Health just dropped an 8-K with fresh financials, time to check their numbers!**
AI Summary
Elevance Health, Inc. filed an 8-K on January 24, 2024, to report its results of operations and financial condition, along with financial statements and exhibits. This filing, under SEC File Number 001-16751, indicates that the company is providing updated financial information to the public. For investors, this matters because it provides the latest official financial health check, which can influence stock price and future investment decisions.
Why It Matters
This filing provides investors with the most current financial performance data for Elevance Health, Inc., which is crucial for evaluating the company's health and making informed investment decisions.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial information, not indicating any specific new risks or adverse events.
Analyst Insight
A smart investor would review the detailed financial statements and exhibits referenced in this 8-K once they become available to understand Elevance Health's current financial performance and operational health.
Key Numbers
- 001-16751 — SEC File Number (identifies Elevance Health's registration with the SEC)
- 20240124 — Filing Date (the date the 8-K was filed with the SEC)
Key Players & Entities
- Elevance Health, Inc. (company) — the registrant filing the 8-K
- 001-16751 (dollar_amount) — the Commission File Number for Elevance Health, Inc.
- January 24, 2024 (date) — the date of the earliest event reported and filing date
- NYSE (company) — the exchange where Elevance Health's Common Stock is registered
- ELV (company) — the trading symbol for Elevance Health's Common Stock
FAQ
What is the primary purpose of this 8-K filing by Elevance Health, Inc.?
The primary purpose of this 8-K filing by Elevance Health, Inc. is to report on 'Results of Operations and Financial Condition' and to include 'Financial Statements and Exhibits' as per the 'ITEM INFORMATION' section.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on 'January 24, 2024', as stated under 'Date of Report (Date of earliest event reported)'.
What is the trading symbol and exchange for Elevance Health, Inc.'s Common Stock?
Elevance Health, Inc.'s Common Stock trades under the symbol 'ELV' on the 'NYSE', as indicated in the 'Securities registered pursuant to Section 12(b) of the Act' table.
What is the business address of Elevance Health, Inc.?
The business address of Elevance Health, Inc. is '220 Virginia Ave Indianapolis, IN 46204', as listed in the filing.
Has Elevance Health, Inc. operated under any former names?
Yes, Elevance Health, Inc. has operated under former names including 'Anthem, Inc.' (changed 20141202), 'WELLPOINT, INC' (changed 20100105), and 'WELLPOINT INC' (changed 20041130), according to the 'FORMER COMPANY' data.
Filing Stats: 1,199 words · 5 min read · ~4 pages · Grade level 15.5 · Accepted 2024-01-24 06:04:59
Key Financial Figures
- $0.01 — ich registered Common Stock, Par Value $0.01 ELV NYSE Indicate by check mark wh
Filing Documents
- d736006d8k.htm (8-K) — 28KB
- d736006dex991.htm (EX-99.1) — 348KB
- g736006g0124055857970.jpg (GRAPHIC) — 6KB
- g736006g0124055858167.jpg (GRAPHIC) — 6KB
- g736006g0124055858278.jpg (GRAPHIC) — 5KB
- g736006g0124055858390.jpg (GRAPHIC) — 4KB
- g736006g0124055858503.jpg (GRAPHIC) — 4KB
- 0001193125-24-013498.txt ( ) — 559KB
- elv-20240124.xsd (EX-101.SCH) — 3KB
- elv-20240124_lab.xml (EX-101.LAB) — 17KB
- elv-20240124_pre.xml (EX-101.PRE) — 11KB
- d736006d8k_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On January 24, 2024, Elevance Health, Inc. issued a press release reporting its financial results for the quarter ended December 31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference. None of the information furnished in Item 2.02 or Exhibit 99.1 hereto shall be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Unless expressly set forth by specific reference in such filings, none of the information furnished in this report shall be incorporated by reference in any filing under the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Exhibit 99.1 Press Release, dated January 24, 2024, reporting Elevance Health, Inc. financial results for the quarter ended December 31, 2023. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as "expect," "feel," "believe," "will," "may," "should," "anticipate," "intend," "estimate," "project," "forecast," "plan" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent required by law, we do not update or revise any forward-looking statements to reflect events or circumstances occurring after the date hereof. These risks and uncertainties include, but are not limited to: trends in healthcare costs and utilization rates; reduced enrollment; our ability to secure and implement sufficient premium rates; the impact of large scale medical emergencies, such as public health epidemics and pandemics, including COVID-19, and other catastrophes; the impact of new or changes in existing federal
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 24, 2024 ELEVANCE HEALTH, INC. By: /s/ Kathleen S. Kiefer Name: Kathleen S. Kiefer Title: Chief Governance Officer and Corporate Secretary